CHADD: Children and Adults with Attention-Deficit/Hyperactivity Disorder
The Relationship Between CHADD & The Drug Companies
The organization CHADD has been a recipient of financial donations and contributions from the drug company Ciba/Novartis for many years.
CHADD received $748,000 from Ciba/Novartis in the period 1991 to 1994 alone. During the periods when CHADD received funding from Ciba/Novartis, CHADD deliberately made efforts to increase the sales of Ritalin, and to increase the supply of methylphenidate ( the generic name for Ritalin ) available in the United States, and to reduce or eliminate laws and restrictions concerning the use of Ritalin and methylphenidate in the United states, all to the financial benefit of Ciba/Novartis.
Ciba/Novartis made such financial contributions with the purpose of advertising and promoting sales of Ritalin - an internationally controlled substance. Ciba/Novartis has thus repeatedly violated Article 10 of the United Nations Convention on Psychotropic Substances, 1019 U.N.T.S. 175 (1971)
Information provided courtesy of www.ritalindeath.com